Janicke, F.

patient cancer tumor breast prognostic model level breast cancer lymph status plasminogen analysis factor activator urokinase-type plasminogen activator pai -2 base model group dataset node-negative value lymph node status system variable prognostic factors adjuvant prognosis inhibitor urokinase curve table 0.0001 menopausal status lymph node-positive patients prognostic value study number tumor size treatment <.001 lymph node-negative patients prognostic score node-positive node-positive patients protein result breast cancer patients grade analyses upa system therapy survival urokinase-type multivariate hormone-receptor status receptor score 10 years cancer institute assay urokinase plasminogen activator adjuvant treatment menopausal multivariable risk groups urokinase system nodal status lymph node-negative adjuvant therapy tissue component pai -2 levels prognostic variables schmitt node-negative patients plasminogen activation multivariate model histologic grade hazard effect